Israel cấp phép thuốc Molnupiravir của Merck, cho phép tiêm liều 4

Bộ Y tế Israel ngày 2/1 thông báo đã cấp phép sử dụng thuốc điều trị COVID-19 do tập đoàn dược phẩm đa quốc gia Merck của Mỹ sản xuất, sau quyết định tương tự đối với thuốc Paxlovid của Pfizer.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Mỹ hủy bỏ kế hoạch áp đặt hạn chế với UAV của Trung Quốc

Mỹ hủy bỏ kế hoạch áp đặt hạn chế với UAV của Trung Quốc

Thế giới
(Baothanhhoa.vn) - Bộ Thương mại Mỹ vừa thông báo hủy bỏ kế hoạch áp đặt các hạn chế đối với máy bay không người lái của Trung Quốc, vốn ban đầu được đề xuất để giải quyết các mối lo ngại về an ninh quốc gia. Động thái này được cho là nhằm tránh gia tăng căng thẳng...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh